Table 2.
Disease Phase | HBeAg | No. of Patients | Serum HBV DNA | Serum HBsAg | Serum HBsAg-HQ | Year | Country Where the Patients Were Enrolled | References | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Correlation Coefficient | p Value | Correlation Coefficient | p Value | Correlation Coefficient | p Value | ||||||
Immune tolerance | Positive | 30 | 0.45 | 0.013 | 0.47 | 0.0095 | 2015 | Germany | [35] | ||
52 | 0.369 | 0.007 | 0.286 | 0.04 | 0.401 | 0.003 | 2014 | Hong Kong | [25] | ||
Immune clearance | Positive | 60 | 0.66 | <0.0001 | 0.53 | <0.0001 | 2015 | Germany | [35] | ||
105 | 0.484 | <0.001 | 0.406 | 0.017 | 0.596 | 0.401 | 2014 | Hong Kong | [25] | ||
Hepatitis | Negative | 50 | 0.74 | <0.0001 | 0.4 | 0.0045 | 2015 | Germany | [35] | ||
97 | 0.537 | <0.001 | 0.245 | <0.001 | 0.401 | <0.001 | 2014 | Hong Kong | [25] | ||
Inactive/quiescent carrier | Negative | 109 | 0.18 | 0.054 | 0.47 | <0.0001 | 2015 | Germany | [35] | ||
95 | 0.472 | <0.001 | 0.388 | <0.001 | 0.605 | <0.001 | 2014 | Hong Kong | [25] |